![Чудовище / The Monster [= Пятый вид: Загадочное чудовище; Воскресшее чудовище; Возрождение] - Альфред Ван Вогт](https://cdn.rusbook.su/s20/5/6/7/3/8/56738.jpg)
Первая клетка. И чего стоит борьба с раком до последнего - Азра Раза
Шрифт:
Интервал:
Закладка:
Yuan Z. Dynamic Plasma MicroRNAs Are Biomarkers for Prognosis and Early Detection of Recurrence in Colorectal Cancer. British Journal of Cancer. 117 (2017): 1202–1210.
Hinkson I., IV et al. A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine. Frontiers in Cell and Developmental Biology, September 21, 2017. doi:10.3389/fcell.2017.00083.
Philippidis A. Next-Gen Diagnostics: Thermo Fisher Scientific, University Hospital Basel Partner to Develop, Validate NGS Cancer Diagnostics. Clinical OMICs. 4, no. 3 (2017). doi:10.1089/clinomi.04.03.17.
BloodPac: Blood Profiling Atlas in Cancer. www.bloodpac.org
Liu M. C. et al. Plasma Cell-Free DNA (cfDNA) Assays for Early Multi-Cancer Detection: The Circulating Cell-Free Genome Atlas (CCGA) Study. Annals of Oncology. 29, supplement 8 (2018): mdy269.048.
Sallam R. M. Proteomics in Cancer Biomarkers Discovery: Challenges and Applications. Disease Markers, 2015. doi:10.1155/2015/321370.
Taylor D., Gercel-Taylor C. MicroRNA Signatures. www.gynecologiconcology-online.net/article/S0090–8258(08)00343–0/fulltext
Peng L. Tissue and Plasma Proteomics for Early Stage Cancer Detection. Molecular Omics. 14 (2018): 405–423.
Tajmul M. D. et al. Identification and Validation of Salivary Proteomic Signatures for Non-Invasive Detection of Ovarian Cancer. International Journal of Biological Macromolecules. 108 (2018): 503–514.
Simpson R. J. et al. Proteomic Profiling of Exosomes: Current Perspectives. Proteomics. 8 (2008): 4083–4099.
Chen Z. et al. Current Applications of Antibody Microarrays. Clinical Proteomics. 15, no. 7 (2018). doi:10.1186/s12014-018-9184-2.
Halvaei S. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer. Nucleic Acid. 10 (2018): 131–141.
Xu R. et al. Extracellular Vesicles in Cancer – Implications for Future Improvements in Cancer Care. Nature Reviews Clinical Oncology. 15, no. 10 (2018): 617–638.
Valentino A. et al. Exosomal MicroRNAs in Liquid Biopsies: Future Biomarkers for Prostate Cancer. Clinical and Translational Oncology. 19 (2017): 651–657.
Rajagopal C., Harikumar K. B. The Origin and Functions of Exosomes in Cancer. Frontiers in Oncology, March 20, 2018. doi:10.3389/fonc.2018.00066.
Rani S. et al. Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling. Methods in Molecular Biology. 784 (2011): 181–195.
Liu F. et al. Exosome-Total-Isolation-Chip (ExoTIC) Device for Isolation of Exosome-Based Biomarkers. US patent application 16/073,577, filed 2019.
Alix-Panabieres C., Pantel K. Circulating Tumor Cells: Liquid Biopsy of Cancer. Clinical Chemistry. 59 (2013): 110–118.
Green B. J. et al. Beyond the Capture of Circulating Tumor Cells: Next-Generation Devices and Materials. Angewandte Chemie International Edition. 55 (2016): 1252–1265.
Vona G. et al. Isolation by Size of Epithelial Tumor Cells: A New Method for the Immunomorphological and Molecular Characterization of Circulating Tumor Cells. American Journal of Pathology. 156, no. 1 (2000): 57–63.
Paterlini-Brechot P., Benali N. L. Circulating Tumor Cells (CTC) Detection: Clinical Impact and Future Directions. Cancer Letters. 253, no. 2 (2007): 180–204.
Hood L., Friend S. H. Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine. Nature Reviews Clinical Oncology. 8 (2011): 184–187.
Cohen J. D. et al. Combined Circulating Tumor DNA and Protein Biomarker-Based Liquid Biopsy for the Earlier Detection of Pancreatic Cancers. PNAS. 114, no. 38 (2017): 10202–10207.
Wang Qing et al. Mutant Proteins as Cancer-Specific Biomarkers. PNAS. 108, no. 6 (2011): 2444–2449.
Lennon A. M. et al. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Research. 74, no. 13 (2014): 3381–3389.
Moses H., III et al. Financial Anatomy of Biomedical Research. JAMA. 294, no. 11 (2005): 1333–1342.
Claridge L. Emily Post: Daughter of the Gilded Age, Mistress of American Manners. New York: Random House, 2008.
Что было потом. Пусть боль кричитKÜbler-Ross E., Kessler D. On Grief and Grieving: Finding the Meaning of Grief Through the Five Stages of Loss. New York: Scribner, 2005.
Robinson K. Robert Frost: ‘The Road Not Taken.’ Our Choices Are Made Clear in Hindsight. Poetry Foundation, May 27, 2016. www.poetryfoundation.org/articles/89511/robert-frost-the-road-not-taken
Fairfield Minuteman Archives, Feb 12, 2004, p. 40. Newspaper Archive.
https://newspaperarchive.com/fairfield-minuteman-feb-12–2004-p-40/
Lang J. Barbara Griffiths: Downsizing Gives Artist Pause to Ponder Her Life and Her Art. CT Post, August 14, 2016. www.ctpost.com/living/article/Barbara-Griffiths-Downsizing-gives-artist-pause-9141213.php
Sontag S. Illness As Metaphor. New York: Farrar, Straus and Giroux, 1978. [Зонтаг С. Болезнь как метафора. М.: Ad Marginem, 2016.]
Bonchek Adams L. Persevere: A Life with Cancer. Lancaster, PA: Bonchek Family Foundation, 2017.
Эпилог. Заря уже занимаетсяWeinberg R. A. Coming Full Circle – From Endless Complexity to Simplicity and Back Again. Cell. 157, no. 1 (2014): 267–271.
Fojo T., Grady C. How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $ 440 Billion Question. JNCI. 101, no. 15 (2009): 1044–1048.
Yachida S. et al. Distant Metastasis Occurs Late During the Genetic Evolution of Pancreatic Cancer. Nature. 467 (2010): 1114–1117.
Desai P. et al. Somatic Mutations Precede Acute Myeloid Leukemia Years Before Diagnosis. Nature Medicine. 24 (2018): 1015–1023.
Ehrenreich B. Pathologies of Hope. Harper’s, February 1, 2007.
https://harpers.org/archive/2007/02/pathologies-of-hope/
Ibn Abi Talib A. Nahjul Balagha: Peak of Eloquence. India: Alwaaz International, 2010.
